Baird Maintains Outperform on Cardinal Health, Raises Price Target to $108
Portfolio Pulse from Benzinga Newsdesk
Baird analyst Eric Coldwell maintains an Outperform rating on Cardinal Health (NYSE:CAH) and raises the price target from $107 to $108.
August 16, 2023 | 12:04 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Baird analyst maintains an Outperform rating on Cardinal Health and raises the price target to $108.
The news is directly about Cardinal Health. The raised price target by Baird analyst indicates a positive outlook for the company, which could lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100